Implementation of clinical pharmacy services in non- academic - - PowerPoint PPT Presentation

implementation of clinical pharmacy services in non
SMART_READER_LITE
LIVE PREVIEW

Implementation of clinical pharmacy services in non- academic - - PowerPoint PPT Presentation

Implementation of clinical pharmacy services in non- academic hospitals: opportunities and links to university programmes Pharm. Elke De Troy 8th june 2006 Content Content 1.Link with university program of Leuven 2.Implementation in a


slide-1
SLIDE 1

Implementation of clinical pharmacy services in non- academic hospitals:

  • pportunities and links to

university programmes

  • Pharm. Elke De Troy

8th june 2006

slide-2
SLIDE 2

Content Content 1.Link with university program of Leuven 2.Implementation in a non-academic hospital 3.Pilot-project on an oncology service 4.Future plan

  • 5. Conclusion and opportunities
slide-3
SLIDE 3

Content Content 1.Link with university program of Leuven 2.Implementation in a non-academic hospital 3.Pilot-project on an oncology service 4.Future plan 5.Conclusion and opportunities

slide-4
SLIDE 4
  • 1. Link
  • 1. Link university

university program program Leuven Leuven

Background Background

  • hospital pharmacist at Virga Jesse Hospital since 1995
  • 2003:Opportunity: fellowship in clinical pharmacy at

university of Leuven Fellowship Fellowship cooperation between

  • faculty of farmaceutical sciences
  • university hospital Gasthuisberg
  • farmaceutical industry
slide-5
SLIDE 5
  • 1. Link
  • 1. Link university

university program program Leuven Leuven

Basic Basic education education to to become become a a hospital hospital pharmacist pharmacist

° ° extensive extensive knowledge knowledge … …

  • pharmacology

pharmacology, , pharmacokinetics pharmacokinetics, , interactions interactions, , antibiotics antibiotics, , cytotoxics cytotoxics, ,… … ° ° but but… …

  • theoretical

theoretical knowledge knowledge

  • insufficiently

insufficiently linked linked to to clinical clinical practice practice ° ° need need for for additive additive knowledge knowledge … …

  • pathophysiology

pathophysiology

  • specific

specific domains domains: intensive care, : intensive care, oncology

  • ncology,

, pediatrics pediatrics…

… => => Refresh Refresh basic basic knowledge knowledge and and s self elf-

  • study

study! !

slide-6
SLIDE 6
  • 1. Link
  • 1. Link university

university program program Leuven Leuven

Fellowship Fellowship trainingscourse trainingscourse of 12

  • f 12 months

months => => mainly mainly practical practical ° ° UZ UZ leuven leuven: : traumatology traumatology and MICU and MICU ° ° teaching teaching hospital hospital in London: 14 in London: 14 days days ⇒ ⇒ posters posters ⇒ ⇒ script script

slide-7
SLIDE 7
  • 1. Link
  • 1. Link university

university program program Leuven Leuven

Develop Develop methodology methodology to to evaluate evaluate medication medication therapy therapy ⇒ ⇒ Start

Start from from pathology pathology, , clinical clinical status, lab parameters, status, lab parameters, medication medication on

  • n

admission admission

⇒ ⇒ Evaluate

Evaluate medication medication therapy therapy: :

  • Medication

Medication on

  • n admission

admission? ?

  • Pathology

Pathology: : what what is is indicated indicated? ?

  • Correct

Correct dose dose and and frequency frequency? ?

  • Correct route of

Correct route of administration administration? ?

  • Interactions

Interactions? ?

  • TDM

TDM? ?

  • Guidelines

Guidelines for for use use of

  • f antibiotics

antibiotics? ?

  • Enteral

Enteral and and parenteral parenteral feeding? feeding?

  • Adverse

Adverse effects effects? ?

slide-8
SLIDE 8

Content Content 1.Link with university program of Leuven 2.Implementation in a non-academic hospital 3.Pilot-project on an oncology service 4.Future plan 5.Conclusion and opportunities

slide-9
SLIDE 9

2.

  • 2. Implementation

Implementation in in non non-

  • academic

academic hospital hospital Implementation in different steps: Implementation in different steps:

1.

  • 1. Preparation in cooperation with medical director

Preparation in cooperation with medical director 2.

  • 2. Discuss with management commission

Discuss with management commission 3.

  • 3. Discuss with physician, head of service

Discuss with physician, head of service

slide-10
SLIDE 10

2.

  • 2. Implementation

Implementation in in non non-

  • academic

academic hospital hospital

→ → determine determine target: target:

  • policy of

policy of “ “patient safety patient safety” ” of VJH

  • f VJH
  • anticipate in

anticipate in “ “medication medication-

  • budget

budget” ” → → determine method determine method: clinical pharmacist : clinical pharmacist ½ ½ time on time on service and service and ½ ½ time in pharmacy time in pharmacy → → choice of service choice of service: :

  • polypharmacy, polypathology

polypharmacy, polypathology

  • patient tour

patient tour => oncology ward => oncology ward

  • consult together

consult together 2.1 Preparation in cooperation with medical director 2.1 Preparation in cooperation with medical director

slide-11
SLIDE 11

2.

  • 2. Implementation

Implementation in in non non-

  • academic

academic hospital hospital

→ → supported supported the proposal the proposal → → agreement: agreement:

  • pilot project

pilot project

  • evaluation after 3,6 and 12 months

evaluation after 3,6 and 12 months

  • plan for future

plan for future 2.2 Discuss with management commission 2.2 Discuss with management commission 2.3 Discuss with oncologist → → determine tasks of clinical pharmacist determine tasks of clinical pharmacist

slide-12
SLIDE 12

Content Content 1.Link with university program of Leuven 2.Implementation in a non-academic hospital 3.Pilot-project on an oncology service 4.Future plan 5.Conclusion and opportunities

slide-13
SLIDE 13

3.

  • 3. Pilot

Pilot project project oncology

  • ncology

Further progress of project Further progress of project → → evaluation 3 months: report interventions evaluation 3 months: report interventions → → evaluation 6 months: individual patient + procedures evaluation 6 months: individual patient + procedures → → endevaluation endevaluation Start: november 2004 Start: november 2004 → → Oncology service: 30 beds, 1700 admissions/yr → → daily work:

  • preparation:°new pts: medical file, nursing file, labs….

° others: daily labs, parameters…

  • patient tour
  • look for: interactions, guidelines, literature…
  • discuss possible interventions with physician
slide-14
SLIDE 14

Report Report interventions interventions

Interventions by clin pharm on oncology service in 11 months

3% 6% 5% 3% 4% 1% 13% 21% 10% 10% 9% 7% 8% adverse reactions dose correction interactions medication error route administration info start product stop product antibiotic guidelines electrolytes pain therapy enteral and parenteral feeding

  • thers

Interventions: every proposal that leads to a change in medication therapy

report in Access-file aim: observe qualitative and financial implications

slide-15
SLIDE 15

Report Report interventions interventions

Rate of acceptancy Rate of acceptancy

1068 133 200 400 600 800 1000 1200

slide-16
SLIDE 16

Procedures: Procedures: standardised standardised schemes schemes

Te bewaren in chemoboekje

Patiëntnaam Boer wortel THERAPIE: mg/m2 * dosis%mg/m2 dosis% Kamernummer B5 Taxol 175 175 100% Gewicht (kg) 70 Lengte (cm) 172 BSA gelimiteerd (m2) 1,83 Carboplatine BSA (m2) 1,83 AUC (waarde 5-7) 5 leeftijd (aantal jaar) 65 serumcreat (mg/ dl) 0,82 schema: q 3 wk Geslacht (M/V) M Cl creat man (ml/min) 88,9 Cl creat vrouw (ml/min) 0,0 88,9 Startdatum 5-okt-05 Cyclus 4 Dag Bijkomende medicatie Aantal

Automatic prescribing by physician

slide-17
SLIDE 17

Procedures: Procedures: standardised standardised schemes schemes

Schema voor verpleging

Cyclus: 4

Boer wortel

Dag: B5 Datum Paraf Hoev. Medicatie Tijd Uur Opmerking Dosis % 4-okt-05 Glucose 5% 1 liter + 20 meq KCL 12 u spoeling geen naschrift maken NaCl 0.9% 1 liter + 20 meq KCL 12 u spoeling geen naschrift maken 5-okt-05 Glucose 5% 1 liter + 20 meq KCL + 4 g NaCl 12 u waakinfuus geen naschrift maken phenergan 1 amp I.M. toedienen 1 uur vóór taxol dexamethasone 20 mg IV in NaCl 0.9% 50 ml toedienen 45 minuten vóór taxol zantac 1 amp I.V. toedienen 30 min vóór taxol kytril 1 amp in NaCl 0.9% 50 ml 10 min toedienen 30 min vóór taxol 320 mg TAXOL in NaCl 0.9% 500 ml 3 u toedienen met pomp, 0.22 micron filter en infuusleidingen zonder weekmakers 100% SPOELEN met 100 ml waakinfuus 10 min 570 mg CARBOPLATINE in glucose 5% 250 ml 30 min Glucose 5% 1 liter + 20 meq KCL 12 uur spoeling geen naschrift maken verdere spoeling navragen indien verder spoeling ndz: naschrift maken Heparine slot 500 E Mee naar huis te geven: Dexamethasone 4 mg 2/d ged. 2 dagen (te starten 12 uur na vorige dexamethasone) Novaban 5 co Litican 12 co zo nodig Bijkomende medicatie voorgeschreven: Aantal stempel en handtekening arts Patiënt Kamernummer

Scheme for administration by nurses

slide-18
SLIDE 18

Procedures: Procedures: standardised standardised schemes schemes

Voorschrift

Boer wortel

Identificatie sticker B5 mg/m2 % dosis lengte (cm) 172 175 taxol 100% gewicht (kg) 70 BSA gelimiteerd (m2) 1,83 AUC 5 carboplatine Datum + Paraf Ap. Dosis Medicatie Hoev 4/10/2005 5/10/2005 KCL 20 meq/ 20 ml 4 x O NaCl 2 g MP 2 x O dexamethasone 20 mg IV in NaCl 0.9% 50 ml 1 x O phenergan 1 amp I.M. 1 x O zantac amp 50 mg 1 x O kytril amp 3 mg 1 x O 320 mg TAXOL in NaCl 0.9% 500 ml macoflex O 570 mg CARBOPLATINE in glucose 5% 250 ml macoflex O Dexamethasone 4 mg PO 4 x O Novaban co 5 x O Litican co 12 x O Glucose 5% 1 liter ECO 3 x O NaCl 0.9 % 1 liter ECO 1 x O NaCl 0.9 % 50 ml VF 1 x O Heparine 1000 E/ 10 ml 1 x O Bijkomende medicatie: Aantal: 65650 3 x Glucose 5% 1000 ml ECO 97030 1 x NaCl 0.9% 1000 ml ECO 180272 4 x KCL 20 meq/ 20 ml MP 180280 2 x NaCL 2 g/ 10 ml MP 500 4 x aacidexam 5 mg amp 119510 1 x phenergan amp 177700 1 x zantac amp 12499 1 x kytril amp 158600 2 x NaCl 0.9% 50 ml VF 5010450 1 x NaCl 0.9% 500 ml macoflex Handtekening en stempel arts 65600LL 1 x Glucose 5% 250 ml macoflex 170505 4 x dexamethasone 4 mg po 97047 5 x novaban co 83610 12 x litican co 211192 1 x heparine 1000 E/ 10 ml Leo 13525 x taxol 100 mg/ 17 ml 11153 x taxol 30 mg/ 5 ml 424136 x carboplatine 150 mg/15 ml Pharmacia 424144 x carboplatine 450 mg/45 ml Pharmacia x MBH 972000 Tarificatie apotheek Patiënt Kamernummer

Prescription pharmacy

slide-19
SLIDE 19

Anticipate Anticipate in in medication medication budget budget

Price Cipro IV 400 mg = 27,88 € Price Cipro PO 500 mg = 1,07 €

ratio cipro IV (in DDD's/ 1000 admission days)/ cipro PO (in DDD's /1000 admission days) on oncology service

0,00 0,25 0,50 0,75 1,00 1,25 1,50 1,75 2,00 2,25 2,50 2,75 3,00 3,25 3,50 3,75 4,00

2 4 / 1 2 4 / 3 2 4 / 5 2 4 / 7 2 4 / 9 2 4 / 1 1 2 5 / 1 2 5 / 3 2 5 / 5 2 5 / 7 2 5 / 9 2 5 / 1 1

Start clin pharm

  • ncology

Start project seq therapy

slide-20
SLIDE 20

Content Content 1.Link with university program of Leuven 2.Implementation in a non-academic hospital 3.Pilot-project on an oncology service 4.Future plan 5.Conclusion and opportunities

slide-21
SLIDE 21
  • 4. Future plan

4.1 Management of the hospital: → Vision text: development of hospital pharmacy next 5-10 years

nurse patient physician

Front office Front office

Clinical pharmacy Procedures for admini- stration of medication Datamanagement MFC en ABcommittee

Back office Back office

Distribution and preparation Logistic and admi- nistrative tasks Sterilization

Pharmaceutical care Pharmaceutical care and and Disease management Disease management

slide-22
SLIDE 22

4.

  • 4. Future

Future plan plan

→ change organogram pharmacy: clinical services

as a separate division

administration and logistics head of administration and logistics CSS CDS head of sterilization pharmacists 1,5 FTE administration and logistics, CSS, CDS pharmacist 2 FTE clinical pharmacy en clinical trials pharmacist 2,5 FTE distribution and production adjunct- head of pharmacy 1 FTE pharmacist, head of service 1 FTE

slide-23
SLIDE 23

4.

  • 4. Future

Future plan plan

4.2 Medical director: consultation of different medical and surgical disciplines 4.3 Plan

  • End 2006: Enlargement of clinical pharmacy

services to 3 wards

  • 5-10 years: every pharmacist spends ½ time on

clinical activities

slide-24
SLIDE 24

Content Content 1.Link with university program of Leuven 2.Implementation in a non-academic hospital 3.Pilot-project on an oncology service 4.Future plan 5.Conclusion and opportunities

slide-25
SLIDE 25

5.

  • 5. Conclusion

Conclusion and and opportunities

  • pportunities
  • clinical pharmacy is possible in a peripheral

hospital

  • pharmaceutical added value for patient

→ positioning of hospital pharmacist in future

  • More rational use of medication

→ medication-budget = opportunity to enlarge clinical activities for pharmacist in Belgium